13th Drug Discovery Innovation Programme (DDIP) in San Francisco, CA

Pharmacology & Pharmaceuticals; Biotechnology & Biomedical

Address: TBA, San Francisco, CA
Date: 21 to 22 Oct '20
Visit Event Website

DDIP has always proven to be a unique platform to meet senior level executives, key decision makers and experts all-around the Pharmaceutical, Biotech and lead scientists making the congress a perfect platform to share experience, foster collaborations to put forward many thought provoking strategies.

  • 12+ Networking Hours
  • 25+ Countries Representation
  • 20+ Keynote Speakers 250+ Pre-Qualified meeting
  • 75:25 Buyers:Sellers
  • 80+ Attendees

Why Attend?

works with associations and companies to help them achieve their marketing objectives through various promotional opportunities. These opportunities are tailored to fit specific marketing goals, in order to maximize the exposure and impact of the partnership.

Heard the word Conference and instantly got bored? Well DDIP is no such Conference. Here the experience of learning is different. With entrancing Discussions about the most recent Innovations, trends and global challenges, DDIP is sure to cater to the unmet needs of the pharma industry.

DDIP will help in building relationships among the professionals from the industry. It’s not just about sitting at a conference and listening to presentations; you’ll get to roam around and connect with the skillful and adept movers and shakers of the industry.

Who Should Attend

Top-level Industry leaders from around 25+ Countries come to join DDIP and leave with an exceptional experience that they return to the conferences year after year. Delegates attending our event are asked to complete a questionnaire, which confirms their R&D budget. 

They also provide details on: 
  • Relevant Drug Discovery phases 
  • Drug Discovery budget of over 1 million Euros​ 
  • Scope of responsibility​ 
  • Purchase plan for Products and services 
  • Geographies of interest​ 
  • Key priorities for the next 6-18 months

  • CEO 
  • CSO 
  • Director Discovery Alliances 
  • VP of Chemistry 
  • VP Target Discovery & Assessment 
  • Senior Director Discovery Research 
  • Senior Director Functional Genomics 
  • Head of R&D Licensing 
  • VP Pharmacology & Preclinical PK/PD 
  • Principal Scientist 
  • Head Pharmacology & Toxicology 
  • Director of Discovery Strategy Portfolio 
  • Executive Director Chemistry 
  • VP Translational Medicine 
  • Head of Drug Design


Get the latest updates



Lonnie Bookbinder


ARIX Precision Medicine

Peter Heifetz

President and CEO

OrPro Therapeutics

Ramesh Baliga

Vice President, Discovery Biology

IGM Biosciences

Volker Schellenberger

President and CEO





Co-Located Events


Get the latest updates




World BI

 Please check the official event website for possible changes before you make any travel arrangements.
Prices are for evaluation only.